0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-02-01 Sage Accounts Production Advanced 2023 - FRS102_2023 9,258 13,196 xbrli:pure xbrli:shares iso4217:GBP 14611910 2024-02-01 2025-01-31 14611910 2025-01-31 14611910 2024-01-31 14611910 2023-01-23 2024-01-31 14611910 2024-01-31 14611910 2023-01-22 14611910 bus:RegisteredOffice 2024-02-01 2025-01-31 14611910 bus:OrdinaryShareClass1 2024-02-01 2025-01-31 14611910 bus:Director1 2024-02-01 2025-01-31 14611910 core:WithinOneYear 2025-01-31 14611910 core:WithinOneYear 2024-01-31 14611910 core:UKTax 2024-02-01 2025-01-31 14611910 core:UKTax 2023-01-23 2024-01-31 14611910 bus:AllOrdinaryShares 2024-02-01 2025-01-31 14611910 bus:AllOrdinaryShares 2023-01-23 2024-01-31 14611910 core:ShareCapital 2025-01-31 14611910 core:ShareCapital 2024-01-31 14611910 core:RetainedEarningsAccumulatedLosses 2025-01-31 14611910 core:RetainedEarningsAccumulatedLosses 2024-01-31 14611910 bus:Director1 2024-01-31 14611910 bus:Director1 2023-01-22 14611910 bus:SmallEntities 2024-02-01 2025-01-31 14611910 bus:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 14611910 bus:SmallCompaniesRegimeForDirectorsReport 2024-02-01 2025-01-31 14611910 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 14611910 bus:FullAccounts 2024-02-01 2025-01-31 14611910 bus:OrdinaryShareClass1 2025-01-31 14611910 bus:OrdinaryShareClass1 2024-01-31
COMPANY REGISTRATION NUMBER: 14611910
EYFitness Limited
Unaudited Financial Statements
31 January 2025
EYFitness Limited
Director's Report
Year ended 31 January 2025
The director presents his report and the unaudited financial statements of the company for the year ended 31 January 2025 .
Director
The director who served the company during the year was as follows:
E Y Yoboue
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 30 October 2025 and signed on behalf of the board by:
E Y Yoboue
Director
Registered office:
4 King Alfred Avenue
London
England
SE6 3HT
EYFitness Limited
Statement of Comprehensive Income
Year ended 31 January 2025
Period from
Year to
23 Jan 23 to
31 Jan 25
31 Jan 24
Note
£
£
Turnover
4
28,426
43,599
Cost of sales
6,229
10,060
--------
--------
Gross profit
22,197
33,539
Distribution costs
793
1,254
Administrative expenses
9,974
15,970
--------
--------
Operating profit
11,430
16,315
--------
--------
Profit before taxation
11,430
16,315
Tax on profit
5
2,172
3,119
--------
--------
Profit for the financial year and total comprehensive income
9,258
13,196
--------
--------
All the activities of the company are from continuing operations.
EYFitness Limited
Statement of Financial Position
31 January 2025
2025
2024
Note
£
£
Current assets
Debtors
7
–
1,200
Cash at bank and in hand
152
3,440
----
-------
152
4,640
Creditors: amounts falling due within one year
8
4,697
6,443
-------
-------
Net current liabilities
4,545
1,803
-------
-------
Total assets less current liabilities
( 4,545)
( 1,803)
-------
-------
Net liabilities
( 4,545)
( 1,803)
-------
-------
Capital and reserves
Called up share capital
9
1
1
Profit and loss account
( 4,546)
( 1,804)
-------
-------
Shareholders deficit
( 4,545)
( 1,803)
-------
-------
For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.
These financial statements were approved by the board of directors and authorised for issue on 30 October 2025 , and are signed on behalf of the board by:
E Y Yoboue
Director
Company registration number: 14611910
EYFitness Limited
Statement of Cash Flows
Year ended 31 January 2025
2025
2024
£
£
Cash flows from operating activities
Profit for the financial year
9,258
13,196
Adjustments for:
Tax on profit
2,172
3,119
Accrued expenses
–
1,000
Changes in:
Trade and other debtors
1,200
( 1,200)
Trade and other creditors
( 799)
799
--------
--------
Cash generated from operations
11,831
16,914
Tax paid
( 3,119)
–
--------
--------
Net cash from operating activities
8,712
16,914
--------
--------
Cash flows from financing activities
Proceeds from issue of ordinary shares
–
1
Proceeds from borrowings
–
1,525
Dividends paid
( 12,000)
( 15,000)
--------
--------
Net cash used in financing activities
( 12,000)
( 13,474)
--------
--------
Net (decrease)/increase in cash and cash equivalents
( 3,288)
3,440
Cash and cash equivalents at beginning of year
3,440
–
-------
-------
Cash and cash equivalents at end of year
152
3,440
-------
-------
EYFitness Limited
Notes to the Financial Statements
Year ended 31 January 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 4 King Alfred Avenue, London, SE6 3HT, England.
2. Statement of compliance
These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances .
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Turnover
Turnover arises from:
Period from
Year to
23 Jan 23 to
31 Jan 25
31 Jan 24
£
£
Sale of goods
28,426
43,599
--------
--------
The whole of the turnover is attributable to the principal activity of the company wholly undertaken in the United Kingdom.
5. Tax on profit
Major components of tax expense
Period from
Year to
23 Jan 23 to
31 Jan 25
31 Jan 24
£
£
Current tax:
UK current tax expense
2,172
3,119
-------
-------
Tax on profit
2,172
3,119
-------
-------
Reconciliation of tax expense
The tax assessed on the profit on ordinary activities for the year is the same as (2024: the same as) the standard rate of corporation tax in the UK of 0.19 % (2024: 0.19 %).
Period from
Year to
23 Jan 23 to
31 Jan 25
31 Jan 24
£
£
Profit on ordinary activities before taxation
11,430
16,315
--------
--------
Profit on ordinary activities by rate of tax
2,172
3,119
--------
--------
6. Dividends
2025
2024
£
£
Dividends paid during the year (excluding those for which a liability existed at the end of the prior year )
12,000
15,000
--------
--------
7. Debtors
2025
2024
£
£
Trade debtors
–
1,200
----
-------
8. Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
–
799
Accruals and deferred income
1,000
1,000
Corporation tax
2,172
3,119
Director loan accounts
1,525
1,525
-------
-------
4,697
6,443
-------
-------
9. Called up share capital
Issued, called up and fully paid
2025
2024
No.
£
No.
£
Ordinary shares of £ 1 each
1
1
1
1
----
----
----
----
10. Analysis of changes in net debt
At 1 Feb 2024
Cash flows
At 31 Jan 2025
£
£
£
Cash at bank and in hand
3,440
(3,288)
152
Debt due within one year
(1,525)
–
(1,525)
-------
-------
-------
1,915
( 3,288)
( 1,373)
-------
-------
-------
EYFitness Limited
Notes to the Financial Statements (continued)
Year ended 31 January 2025
11. Director's advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
Balance brought forward and outstanding
2025
2024
£
£
E Y Yoboue
( 1,525)
( 1,525)
-------
-------